Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Qtr timing

Qtr timing

posted on Jun 02, 2006 10:41AM
There could be something to the timing of this deal occurring 2 days after the close of a quarter. This means that the terms of the deal (which in previous deals have not been disclosed with the announcement) will not have to be announced for another 3 months + in their quarterly SEC filing.

This is probably another strategic move so that the numbers involved in this deal do not enter into the public arena while ongoing negotations continue with the J3. Given that an expected Markman date could be announced within the next 3 months it continues to give Alliacense leverage in negotiations. More ammo for the notion that the J3 has their backs against the wall.

Very interesting -- your thoughts?

MW

Share
New Message
Please login to post a reply